1
|
Li YL. Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure. Int J Mol Sci 2022; 23:ijms232113311. [PMID: 36362099 PMCID: PMC9653702 DOI: 10.3390/ijms232113311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2022] [Revised: 10/28/2022] [Accepted: 10/29/2022] [Indexed: 11/06/2022] Open
Abstract
Heart failure (HF) is a major public health problem worldwide, especially coronary heart disease (myocardial infarction)-induced HF with reduced ejection fraction (HFrEF), which accounts for over 50% of all HF cases. An estimated 6 million American adults have HF. As a major feature of HF, cardiac sympathetic overactivation triggers arrhythmias and sudden cardiac death, which accounts for nearly 50–60% of mortality in HF patients. Regulation of cardiac sympathetic activation is highly integrated by the regulatory circuitry at multiple levels, including afferent, central, and efferent components of the sympathetic nervous system. Much evidence, from other investigators and us, has confirmed the afferent and central neural mechanisms causing sympathoexcitation in HF. The stellate ganglion is a peripheral sympathetic ganglion formed by the fusion of the 7th cervical and 1st thoracic sympathetic ganglion. As the efferent component of the sympathetic nervous system, cardiac postganglionic sympathetic neurons located in stellate ganglia provide local neural coordination independent of higher brain centers. Structural and functional impairments of cardiac postganglionic sympathetic neurons can be involved in cardiac sympathetic overactivation in HF because normally, many effects of the cardiac sympathetic nervous system on cardiac function are mediated via neurotransmitters (e.g., norepinephrine) released from cardiac postganglionic sympathetic neurons innervating the heart. This review provides an overview of cardiac sympathetic remodeling in stellate ganglia and potential mechanisms and the role of cardiac sympathetic remodeling in cardiac sympathetic overactivation and arrhythmias in HF. Targeting cardiac sympathetic remodeling in stellate ganglia could be a therapeutic strategy against malignant cardiac arrhythmias in HF.
Collapse
Affiliation(s)
- Yu-Long Li
- Department of Emergency Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA; ; Tel.: +1-402-559-3016; Fax: +1-402-559-9659
- Department of Cellular & Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
| |
Collapse
|
2
|
de León A, Gibon J, Barker PA. APP Genetic Deficiency Alters Intracellular Ca 2+ Homeostasis and Delays Axonal Degeneration in Dorsal Root Ganglion Sensory Neurons. J Neurosci 2022; 42:6680-6691. [PMID: 35882556 PMCID: PMC9436018 DOI: 10.1523/jneurosci.0162-22.2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 06/08/2022] [Accepted: 07/11/2022] [Indexed: 11/21/2022] Open
Abstract
The activation of self-destructive cellular programs helps sculpt the nervous system during development, but the molecular mechanisms used are not fully understood. Prior studies have investigated the role of the APP in the developmental degeneration of sensory neurons with contradictory results. In this work, we sought to elucidate the impact of APP deletion in the development of the sensory nervous system in vivo and in vitro. Our in vivo data show an increase in the number of sciatic nerve axons in adult male and female APP-null mice, consistent with the hypothesis that APP plays a pro-degenerative role in the development of peripheral axons. In vitro, we show that genetic deletion of APP delays axonal degeneration triggered by nerve growth factor deprivation, indicating that APP does play a pro-degenerative role. Interestingly, APP depletion does not affect caspase-3 levels but significantly attenuates the rise of axoplasmic Ca2+ that occurs during degeneration. We examined intracellular Ca2+ mechanisms that could be involved and found that APP-null DRG neurons had increased Ca2+ levels within the endoplasmic reticulum and enhanced store-operated Ca2+ entry. We also observed that DRG axons lacking APP have more mitochondria than their WT counterparts, but these display a lower mitochondrial membrane potential. Finally, we present evidence that APP deficiency causes an increase in mitochondrial Ca2+ buffering capacity. Our results support the hypothesis that APP plays a pro-degenerative role in the developmental degeneration of DRG sensory neurons, and unveil the importance of APP in the regulation of calcium signaling in sensory neurons.SIGNIFICANCE STATEMENT The nervous system goes through a phase of pruning and programmed neuronal cell death during development to reach maturity. In such context, the role played by the APP in the peripheral nervous system has been controversial, ranging from pro-survival to pro-degenerative. Here we present evidence in vivo and in vitro supporting the pro-degenerative role of APP, demonstrating the ability of APP to alter intracellular Ca2+ homeostasis and mitochondria, critical players of programmed cell death. This work provides a better understanding of the physiological function of APP and its implication in developmental neuronal death in the nervous system.
Collapse
Affiliation(s)
- Andrés de León
- University of British Columbia Okanagan, Kelowna, British Columbia V1V 1V7, Canada
| | - Julien Gibon
- University of British Columbia Okanagan, Kelowna, British Columbia V1V 1V7, Canada
| | - Philip A Barker
- University of British Columbia Okanagan, Kelowna, British Columbia V1V 1V7, Canada
| |
Collapse
|
3
|
Almasieh M, Faris H, Levin LA. Pivotal roles for membrane phospholipids in axonal degeneration. Int J Biochem Cell Biol 2022; 150:106264. [PMID: 35868612 DOI: 10.1016/j.biocel.2022.106264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2022] [Revised: 07/16/2022] [Accepted: 07/17/2022] [Indexed: 10/17/2022]
Abstract
Membrane phospholipids are critical components of several signaling pathways. Maintained in a variety of asymmetric distributions, their trafficking across the membrane can be induced by intra-, extra-, and intercellular events. A familiar example is the externalization of phosphatidylserine from the inner leaflet to the outer leaflet in apoptosis, inducing phagocytosis of the soma. Recently, it has been recognized that phospholipids in the axonal membrane may be a signal for axonal degeneration, regeneration, or other processes. This review focuses on key recent developments and areas for ongoing investigations. KEY FACTS: Phosphatidylserine externalization propagates along an axon after axonal injury and is delayed in the Wallerian degeneration slow (WldS) mutant. The ATP8A2 flippase mutant has spontaneous axonal degeneration. Microdomains of axonal degeneration in spheroid bodies have differential externalization of phosphatidylserine and phosphatidylethanolamine. Phospholipid trafficking could represent a mechanism for coordinated axonal degeneration and elimination, i.e. axoptosis, analogous to apoptosis of the cell body.
Collapse
Affiliation(s)
- Mohammadali Almasieh
- Department of Ophthalmology and Visual Sciences, McGill University, Montreal, Canada
| | - Hannah Faris
- Department of Ophthalmology and Visual Sciences, McGill University, Montreal, Canada
| | - Leonard A Levin
- Department of Ophthalmology and Visual Sciences, McGill University, Montreal, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
| |
Collapse
|
4
|
Abstract
The sympathetic nervous system prepares the body for 'fight or flight' responses and maintains homeostasis during daily activities such as exercise, eating a meal or regulation of body temperature. Sympathetic regulation of bodily functions requires the establishment and refinement of anatomically and functionally precise connections between postganglionic sympathetic neurons and peripheral organs distributed widely throughout the body. Mechanistic studies of key events in the formation of postganglionic sympathetic neurons during embryonic and early postnatal life, including axon growth, target innervation, neuron survival, and dendrite growth and synapse formation, have advanced the understanding of how neuronal development is shaped by interactions with peripheral tissues and organs. Recent progress has also been made in identifying how the cellular and molecular diversity of sympathetic neurons is established to meet the functional demands of peripheral organs. In this Review, we summarize current knowledge of signalling pathways underlying the development of the sympathetic nervous system. These findings have implications for unravelling the contribution of sympathetic dysfunction stemming, in part, from developmental perturbations to the pathophysiology of peripheral neuropathies and cardiovascular and metabolic disorders.
Collapse
|
5
|
Yong Y, Hunter-Chang S, Stepanova E, Deppmann C. Axonal spheroids in neurodegeneration. Mol Cell Neurosci 2021; 117:103679. [PMID: 34678457 PMCID: PMC8742877 DOI: 10.1016/j.mcn.2021.103679] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 10/12/2021] [Accepted: 10/15/2021] [Indexed: 10/20/2022] Open
Abstract
Axonal spheroids are bubble-like biological features that form on most degenerating axons, yet little is known about their influence on degenerative processes. Their formation and growth has been observed in response to various degenerative triggers such as injury, oxidative stress, inflammatory factors, and neurotoxic molecules. They often contain cytoskeletal elements and organelles, and, depending on the pathological insult, can colocalize with disease-related proteins such as amyloid precursor protein (APP), ubiquitin, and motor proteins. Initial formation of axonal spheroids depends on the disruption of axonal and membrane tension governed by cytoskeleton structure and calcium levels. Shortly after spheroid formation, the engulfment signal phosphatidylserine (PS) is exposed on the outer leaflet of spheroid plasma membrane, suggesting an important role for axonal spheroids in phagocytosis and debris clearance during degeneration. Spheroids can grow until they rupture, allowing pro-degenerative factors to exit the axon into extracellular space and accelerating neurodegeneration. Though much remains to be discovered in this area, axonal spheroid research promises to lend insight into the etiologies of neurodegenerative disease, and may be an important target for therapeutic intervention. This review summarizes over 100 years of work, describing what is known about axonal spheroid structure, regulation and function.
Collapse
Affiliation(s)
- Yu Yong
- Department of Biology, University of Virginia, Charlottesville, VA 22903, USA
| | - Sarah Hunter-Chang
- Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22903, USA
| | - Ekaterina Stepanova
- Department of Biology, University of Virginia, Charlottesville, VA 22903, USA
| | - Christopher Deppmann
- Department of Biology, University of Virginia, Charlottesville, VA 22903, USA; Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22903, USA.
| |
Collapse
|
6
|
Palumbo A, Grüning P, Landt SK, Heckmann LE, Bartram L, Pabst A, Flory C, Ikhsan M, Pietsch S, Schulz R, Kren C, Koop N, Boltze J, Madany Mamlouk A, Zille M. Deep Learning to Decipher the Progression and Morphology of Axonal Degeneration. Cells 2021; 10:cells10102539. [PMID: 34685519 PMCID: PMC8534012 DOI: 10.3390/cells10102539] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 09/19/2021] [Accepted: 09/22/2021] [Indexed: 11/16/2022] Open
Abstract
Axonal degeneration (AxD) is a pathological hallmark of many neurodegenerative diseases. Deciphering the morphological patterns of AxD will help to understand the underlying mechanisms and develop effective therapies. Here, we evaluated the progression of AxD in cortical neurons using a novel microfluidic device together with a deep learning tool that we developed for the enhanced-throughput analysis of AxD on microscopic images. The trained convolutional neural network (CNN) sensitively and specifically segmented the features of AxD including axons, axonal swellings, and axonal fragments. Its performance exceeded that of the human evaluators. In an in vitro model of AxD in hemorrhagic stroke induced by the hemolysis product hemin, we detected a time-dependent degeneration of axons leading to a decrease in axon area, while axonal swelling and fragment areas increased. Axonal swellings preceded axon fragmentation, suggesting that swellings may be reliable predictors of AxD. Using a recurrent neural network (RNN), we identified four morphological patterns of AxD (granular, retraction, swelling, and transport degeneration). These findings indicate a morphological heterogeneity of AxD in hemorrhagic stroke. Our EntireAxon platform enables the systematic analysis of axons and AxD in time-lapse microscopy and unravels a so-far unknown intricacy in which AxD can occur in a disease context.
Collapse
Affiliation(s)
- Alex Palumbo
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
- Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany
| | - Philipp Grüning
- Institute for Neuro- and Bioinformatics, University of Lübeck, 23562 Lübeck, Germany; (P.G.); (A.M.M.)
| | - Svenja Kim Landt
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
| | - Lara Eleen Heckmann
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
| | - Luisa Bartram
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
| | - Alessa Pabst
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
| | - Charlotte Flory
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
| | - Maulana Ikhsan
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
- Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany
- Faculty of Medicine, Malikussaleh University, Lhokseumawe 24355, Indonesia
| | - Sören Pietsch
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
- Department of Neonatology, Universitätsklinikum Leipzig, 04103 Leipzig, Germany
| | - Reinhard Schulz
- Wissenschaftliche Werkstätten, University of Lübeck, 23562 Lübeck, Germany;
| | - Christopher Kren
- Medical Laser Center Lübeck GmbH, 23562 Lübeck, Germany; (C.K.); (N.K.)
| | - Norbert Koop
- Medical Laser Center Lübeck GmbH, 23562 Lübeck, Germany; (C.K.); (N.K.)
| | - Johannes Boltze
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
- School of Life Sciences, The University of Warwick, Gibbet Hill Campus, Coventry CV4 7AL, UK
| | - Amir Madany Mamlouk
- Institute for Neuro- and Bioinformatics, University of Lübeck, 23562 Lübeck, Germany; (P.G.); (A.M.M.)
| | - Marietta Zille
- Fraunhofer Research and Development Center for Marine and Cellular Biotechnology EMB, 23562 Lübeck, Germany; (A.P.); (S.K.L.); (L.E.H.); (L.B.); (A.P.); (C.F.); (M.I.); (S.P.); (J.B.)
- Institute for Medical and Marine Biotechnology, University of Lübeck, 23562 Lübeck, Germany
- Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany
- Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, 1090 Vienna, Austria
- Correspondence:
| |
Collapse
|
7
|
Yong Y, Gamage K, Cushman C, Spano A, Deppmann C. Regulation of degenerative spheroids after injury. Sci Rep 2020; 10:15472. [PMID: 32963272 PMCID: PMC7508847 DOI: 10.1038/s41598-020-71906-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Accepted: 08/05/2020] [Indexed: 12/26/2022] Open
Abstract
Neuronal injury leads to rapid, programmed disintegration of axons distal to the site of lesion. Much like other forms of axon degeneration (e.g. developmental pruning, toxic insult from neurodegenerative disorder), Wallerian degeneration associated with injury is preceded by spheroid formation along axons. The mechanisms by which injury leads to formation of spheroids and whether these spheroids have a functional role in degeneration remain elusive. Here, using neonatal mouse primary sympathetic neurons, we investigate the roles of players previously implicated in the progression of Wallerian degeneration in injury-induced spheroid formation. We find that intra-axonal calcium flux is accompanied by actin-Rho dependent growth of calcium rich axonal spheroids that eventually rupture, releasing material to the extracellular space prior to catastrophic axon degeneration. Importantly, after injury, Sarm1-/- and DR6-/-, but not Wlds (excess NAD+) neurons, are capable of forming spheroids that eventually rupture, releasing their contents to the extracellular space to promote degeneration. Supplementation of exogenous NAD+ or expressing WLDs suppresses Rho-dependent spheroid formation and degeneration in response to injury. Moreover, injured or trophically deprived Sarm1-/- and DR6-/-, but not Wlds neurons, are resistant to degeneration induced by conditioned media collected from wild-type axons after spheroid rupture. Taken together, these findings place Rho-actin and NAD+ upstream of spheroid formation and may suggest that other mediators of degeneration, such as DR6 and SARM1, mediate post-spheroid rupture events that lead to catastrophic axon disassembly.
Collapse
Affiliation(s)
- Yu Yong
- Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA
| | - Kanchana Gamage
- Amgen, Massachusetts and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA
| | - Courtny Cushman
- Department of Neuroscience and Biomedical Engineering, University of Virginia, Charlottesville, VA, 22904-4328, USA
| | - Anthony Spano
- Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA
| | - Christopher Deppmann
- Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA.
- Department of Neuroscience and Biomedical Engineering, University of Virginia, Charlottesville, VA, 22904-4328, USA.
- Department of Cell Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA.
| |
Collapse
|